Published online before print December 28, 2007

This Article Full Text (Rapid PDF) All Versions of this Article: jmoldx.2008.070028v1 10/1/28    most recent Purchase Article View Shopping Cart Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Gerriets, J. E. Articles by Gebhart, C. L. Search for Related Content PubMed PubMed Citation Articles by Gerriets, J. E. Articles by Gebhart, C. L.

Copyright © 2008 American Society for Investigative Pathology
Journal of Molecular Diagnostics, doi:10.2353/jmoldx.2008.070028

Accepted for publication August 21, 2007.

Article

Implementation of a T4 Extraction Control for Molecular Assays of Cerebrospinal Fluid and Stool Specimens

From the Department of Pathology and Microbiology, University of Nebraska Medical Center, College of Medicine, Omaha, Nebraska

^@ To whom correspondence should be addressed. E-mail: cgebhart{at}unmc.edu.

	Abstract

The use of appropriate extraction and amplification controls for acellular specimens is not standardized in the clinical laboratory community. Extraction controls and checks for inhibitors of amplification in cellular specimens are most often accomplished by amplification of an internal human genomic target. This approach is not feasible for acellular specimens, which may contain little or no amplifiable genomic material. Other specimen types, such as stool, frequently contain amplification inhibitors. Failure to test for these inhibitors can result in the reporting of false-negative results. The goal of this study was to evaluate the use of a T4 bacteriophage as an extraction and amplification control for acellular specimens. The T4 bacteriophage assay was evaluated for use as a control in 290 specimens, including cerebrospinal fluid, serum, and filtered stool. Extraction procedures on two automated instruments were assessed, including the Roche MagNAPure Compact (Roche Diagnostics, Indianapolis, IN) and the QIAGEN BioRobot M48 (QIAGEN, Valencia, CA), along with the manual QIAGEN extraction method. The T4 bacteriophage can be extracted reliably and reproducibly from cerebral spinal fluid, serum, and filtered stool and, therefore, is useful as both an extraction control and inhibitor check for these specimen sources.